In hypoglycemia unaware patients, CGM provides the required information needed for enhanced decision making support to improve glycemic control and help eliminate severe hypoglycemia. In this observational study, severe hypoglycemia incidents...

In this open-label, single-arm, multicenter clinical study, the Dexcom G4® PLATINUM Continuous Glucose Monitoring (CGM) System (which uses the same software 505 as the Dexcom G5 Mobile CGM System) was evaluated for accuracy in 51...

Persistent use of a continuous glucose monitoring (CGM) system is tied to the sensor accuracy, particularly in the pediatric population who experience greater glycemic variability and wider glycemic excursions than adults. Clinical peformance...

In this first-of-its kind clinical trial, the benefit of continuous glucose monitoring (CGM) use by patients on multiple daily injections (MDI) insulin therapy was investigated. The evidence was resounding—patients on MDI demonstrated significant...

Published in 2008 by the Juvenile Diabetes Research Foundation (JDRF), results from this landmark randomized, controlled trial was the first study to provide clear evidence of improved glycemic outcomes with the use of continuous glucose...

In this novel study, investigators examined not only the benefits of continuous glucose monitoring (CGM) augmented insulin therapy, they also looked at the impact of CGM separately in subjects on multiple daily injection (MDI) regimen vs. insulin...

Pages